https://www.selleckchem.com/pr....oducts/wnk-in-11.htm
MFI obtained with positive control sera were also lower with FcMonoIgG. In kidney transplant recipient's sera, the number of antigenic specificities detected by each secondary antibody was comparable, for dnDSA as well as for non DSA. In conclusion, decision thresholds must be refined when changing the secondary tracing reagent in SAFB assays. FcMonoIgG did not demonstrate any superiority over IgHPolyFab for monitoring HLA antibodies. This article is protected by copyright. All rights reserved.As part of the continuing efforts in lign
Mi piace
Commento
Condividi
